These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15390014)

  • 1. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.
    Sommer U; Hummel T; Cormann K; Mueller A; Frasnelli J; Kropp J; Reichmann H
    Mov Disord; 2004 Oct; 19(10):1196-202. PubMed ID: 15390014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
    Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
    Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Presymptomatic detection of Parkinson's disease].
    Berendse HW; Booij J; Stoffers D; Ponsen MM; Hijman R; Wolters ECh
    Tijdschr Gerontol Geriatr; 2002 Apr; 33(2):70-7. PubMed ID: 12012945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical (premotor) Parkinson's disease.
    Wolters EC; Francot C; Bergmans P; Winogrodzka A; Booij J; Berendse HW; Stoof JC
    J Neurol; 2000 Apr; 247 Suppl 2():II103-9. PubMed ID: 10991655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.
    Spiegel J; Hellwig D; Möllers MO; Behnke S; Jost W; Fassbender K; Samnick S; Dillmann U; Becker G; Kirsch CM
    Brain; 2006 May; 129(Pt 5):1188-93. PubMed ID: 16513685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.
    Lobsien E; Schreiner S; Plotkin M; Kupsch A; Schreiber SJ; Doepp F
    Mov Disord; 2012 Mar; 27(3):450-3. PubMed ID: 22237792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Parkinson's disease - why, when, and how?
    Postuma RB; Montplaisir J
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S105-9. PubMed ID: 20082967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory dysfunction in Parkinson's disease.
    Kranick SM; Duda JE
    Neurosignals; 2008; 16(1):35-40. PubMed ID: 18097158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
    Izawa MO; Miwa H; Kajimoto Y; Kondo T
    Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT.
    Unger MM; Möller JC; Stiasny-Kolster K; Mankel K; Berg D; Walter U; Hoeffken H; Mayer G; Oertel WH
    Mov Disord; 2008 Mar; 23(4):596-9. PubMed ID: 18175346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder.
    Fantini ML; Postuma RB; Montplaisir J; Ferini-Strambi L
    Brain Res Bull; 2006 Oct; 70(4-6):386-90. PubMed ID: 17027774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic hyposmia as a preclinical sign of Parkinson's disease.
    Ponsen MM; Stoffers D; Booij J; van Eck-Smit BL; Wolters ECh; Berendse HW
    Ann Neurol; 2004 Aug; 56(2):173-81. PubMed ID: 15293269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
    Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
    Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT.
    Stokkel MP; Dibbets-Schneider P; Koestering E; Dragoiescu C; Blokland KA
    J Nucl Med Technol; 2007 Mar; 35(1):21-6. PubMed ID: 17337653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory dysfunction as a diagnostic marker for Parkinson's disease.
    Haehner A; Hummel T; Reichmann H
    Expert Rev Neurother; 2009 Dec; 9(12):1773-9. PubMed ID: 19951136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfaction and apathy in Parkinson's disease.
    Cramer CK; Friedman JH; Amick MM
    Parkinsonism Relat Disord; 2010 Feb; 16(2):124-6. PubMed ID: 19783195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.
    Bártová P; Kraft O; Bernátek J; Havel M; Ressner P; Langová K; Herzig R; Skoloudík D
    Ultrasound Med Biol; 2014 Oct; 40(10):2365-71. PubMed ID: 25194454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease.
    Kim JY; Lee WY; Chung EJ; Dhong HJ
    Mov Disord; 2007 Aug; 22(11):1563-6. PubMed ID: 17534948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phantosmias and Parkinson disease.
    Landis BN; Burkhard PR
    Arch Neurol; 2008 Sep; 65(9):1237-9. PubMed ID: 18779429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.